Metabolic Testing Market projected to reach US$ 596.3 Million by 2022, says Coherent Market Insights
Metabolic testing refers to the process of assessing an individual’s metabolic rate and energy expenditure. This testing helps in determining the efficiency of an individual’s metabolism and provides valuable insights into their overall health and wellness. The increasing prevalence of lifestyle disorders, such as diabetes and obesity, coupled with the growing focus on preventive healthcare, has significantly driven the demand for metabolic testing.
The metabolic testing market is projected to reach US$ 596.3 million by 2022, with a CAGR of 7.6% during the forecast period of 2022-2030. Factors such as technological advancements in metabolic testing devices, rising healthcare expenditure, and growing awareness regarding the benefits of metabolic testing are expected to propel market growth.
Market Key Trends:
One key trend shaping the metabolic testing market is the increasing adoption of portable metabolic testing devices. These devices offer the advantage of convenience and portability, allowing individuals to monitor their metabolism and energy expenditure in real-time, even outside of clinical settings.
Portable metabolic testing devices have gained popularity, especially among athletes and fitness enthusiasts, as they enable accurate measurement of metabolic parameters during physical activities. Moreover, the advancements in sensor technology and wireless connectivity have enhanced the usability and accessibility of these devices. The convenience offered by portable metabolic testing devices is expected to drive their demand and contribute to the market growth in the coming years.
The metabolic testing market can be segmented based on product type, technology, application, and end user. In terms of product type, the market can be divided into stationary metabolic systems and portable metabolic systems. The portable metabolic systems segment is projected to dominate the market during the forecast period. This can be attributed to the increasing demand for point-of-care testing and the convenience offered by portable devices for conducting metabolic tests. Portable metabolic systems allow for testing outside of clinical settings, enabling athletes, fitness enthusiasts, and individuals seeking weight management to track their metabolic rates on the go. The growing awareness about the importance of metabolic health and the increasing adoption of personalized fitness and wellness regimens are further fueling the demand for portable metabolic testing devices.
The Global Metabolic Testing Market Demand is expected to witness high growth, exhibiting a CAGR of 7.6% over the forecast period from 2022 to 2030. This growth can be attributed to several factors. Firstly, there is a growing prevalence of metabolic disorders such as diabetes and obesity worldwide. The increasing incidence of these conditions has created a need for accurate and reliable metabolic testing to aid in diagnosis, treatment planning, and monitoring of patients. Furthermore, the rising awareness about the importance of metabolic health and the growing adoption of preventive healthcare practices are driving the demand for metabolic testing. Additionally, technological advancements in metabolic testing devices, such as the development of portable and user-friendly systems, are also contributing to market growth.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the metabolic testing market. This can be attributed to factors such as the high prevalence of metabolic disorders in the region, the presence of a well-established healthcare infrastructure, and the availability of advanced testing facilities. Moreover, increasing government initiatives to promote preventive healthcare and the growing focus on personalized medicine are further driving the demand for metabolic testing in North America.
Key players operating in the metabolic testing market include COSMED srl, Vyaire Medical, Inc., Geratherm Medical AG, MGC Diagnostics Corporation, CORTEX Biophysik GmbH, General Electric Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc., AEI Technologies, Inc., KORR Medical Technologies, Inc., Iworx Systems, GE Healthcare, Hologic, Inc, Geratherm Medical AG, and Parvo Medics. These key players are focusing on strategies such as product launches, partnerships, collaborations, and acquisitions to strengthen their market position and expand their product portfolios. for example, COSMED srl’s indirect subsidiary KORR Medical Technologies, Inc. specializes in metabolic testing and offers a wide range of metabolic testing devices for various applications.